|
|
Sample Profile
| AAIPHARMA
INC
www.aaipharma.com |
| Industry
Group Code: 541710 |
Salaries/Benefits
Rating: 2 (1 is the highest 5 is the
lowest) |
| Ranks
within this company's industry group: |
Sales:
2 |
Profits:
2 |
| RECOMMENDED
FOR THESE CAREERS:
("Y" = Yes) |
| Management: |
| Management
Trainees: |
|
| Experienced
Mgt.: |
Y |
| International
Bus.: |
Y |
| MBA
Grads.: |
Y
|
|
| Sales/Marketing: |
| Marketing
Pros: |
Y |
| Retail
Sales: |
|
| Commercial/Ind.: |
|
| Sales
Trainees: |
|
| Advertising
Pros.: |
|
|
| Liberal
Arts: |
| Gen.
Writing/Editing: |
|
| Technical
Writing: |
Y |
| Graphic
Arts/Photo.: |
|
| Music: |
|
| Broadcasting: |
|
| Other: |
|
|
| Information
Systems: |
| Information
Mgt.: |
Y |
| Software
Dev.: |
Y |
| Hardware
Dev.: |
|
| Systems
Integration: |
Y |
| Consulting/Other:
|
|
|
| Professionals: |
| Finance/Acct.: |
Y |
| Law: |
Y |
| HR/Other: |
Y |
| Training: |
|
| Health
Care: |
Y |
| Consulting:
|
Y |
|
| Tech/Scientific: |
| Engineers,
Elec.: |
Y |
| Engineers,
Other: |
|
| Health
& Lab: |
Y |
| Scientists/Research: |
Y |
| Petroleum/Chem.: |
|
| Math
and Other: |
Y |
|
| TYPES
OF BUSINESS: |
GROWTH
PLANS/SPECIAL FEATURES: |
|
Research
and Development Services-Pharmaceuticals
Analytical Testing
Acquisition and Commercialization of Drugs
Contract Manufacturing for Clinical Trial Periods
Formulations Development
Regulatory Affairs Consulting
Specialty Pharmaceuticals Manufacturing and Distribution
Microbiology Testing Services |
AaiPharma,
Inc., formerly Applied Analytical Industries, Inc.,
is a specialty pharmaceutical and product development
company with comprehensive drug development capabilities
in the United States, Europe and Asia. The company
partners with pharmaceutical companies on both a
fee-for-service and royalty and milestone payment
basis, providing the expertise and knowledge to
create quality health care products. The firm has
earned a reputation for solving complex pharmaceutical
challenges utilizing analytical testing and formulations
development techniques, as well as validation and
regulatory affairs support services. AaiPharma operates
in three divisions: pharmaceuticals, research and
development and international. The pharmaceuticals
division acquires and commercializes branded pharmaceutical
products in targeted therapeutic classes. The firm
has acquired the drugs Aquasol, Brethine, Darvon
and Darvocet. The research and development division
provides research and development expertise and
maintains a portfolio of drug-delivery technologies
and intellectual property rights, which the company
uses to develop better and cheaper drugs. The international
division offers a comprehensive range of pharmaceutical
product development services to international customers.
Recently, AaiPharma signed a definitive merger agreement
with CIMA, a developer and manufacturer of prescription
and over-the-counter drugs. The merger will create
the leading science-based specialty pharmaceutical
company, with expected 2003 revenues between $350
and $365 million.
AAIPharma
is a fast-paced, growing and focused employer that
is looking for employees who want to change lives
through medicine.
|
| BRANDS/DIVISIONS/AFFILIATES: |
NeoSan
Pharmaceuticals
Applied Analytical Industries, Inc.
AAI International
Darvocet
Aquasol
Brethine
Darvon
CIMA |
CONTACTS:
Note:
Officers with more than one job title may be intentionally
listed here more than once. |
Philip
S. Tabbiner, CEO
Philip S. Tabbiner, Pres.
William L. Ginna, Jr., Exec. VP/CFO
Bowin Lindgren, VP-Human Resources
Frederick D. Sancilio, Chief Scientific Officer
Gregory S. Bentley, General Counsel
William H. Underwood, VP-Corp. Dev.
Andrea L. Johnston, VP-Corp. Comm.
George Van Lear, Pres.-Research and Dev.
David M. Hurley, Pres.-Pharmaceuticals
Vijay Aggarwal, Pres.-Dev. Services
James B. Sloan, Sr. VP-Corp. Finance
Frederick D. Sancilio, Chmn. |
| Phone:
910-254-7000 |
Fax:
910-815-2300 |
| Toll-Free:
800-575-4224 |
|
Address:
2320 Scientific Park Dr.,
Wilmington, NC 28405 US
|
| Internet
Address: www.aaipharma.com |
| FINANCIALS: Sales
and profits are in thousands of dollars-add 000 to
get the full amount. Year 2003 note: Complete fiscal
2003 results were not available for all companies
at press time. For this company, year 2003 is for
9 months. |
2001
Sales: $205,793 ( 9 months)
2000 Sales: $230,500
1999 Sales: $141,100
1998 Sales: $104,245
1997 Sales: $102,175 |
2001
Profits: $15,144 ( 9 months)
2000 Profits: $24,072
1999 Profits: $5,900
1998 Profits: -$402
1997 Profits: -$7,913 |
Employees: 1,160
Fiscal Year Ends: 12/31
|
| SALARIES/BENEFITS: |
Pension
Plan:
Savings Plan: |
ESOP
Stock Plan:
Stock Purch. Plan: |
Profit
Sharing: |
Highest
Exec Salary: $ 400,000
Second Highest Salary: $ 285,000 |
Bonus:
$287,000
Bonus: $260,750 |
| COMPETITIVE
ADVANTAGE: |
| Offers
an extensive portfolio of high-quality drug development
and support services. |
| OTHER
THOUGHTS: |
Stock
Ticker:
AAII
|
LOCATIONS:
("Y" = Yes) |
Apparent
Women Officers or Directors: 1
Hot Spot for Advancement for Women/Minorities: |
West:
Y |
Southwest:
|
Midwest:
Y |
Southeast:
Y |
Northeast:
Y |
International:
Y |
|
Back
to Plunkett's Companion to The Almanac of American Employers
|